Clinical Trial Update: A PhaseⅠStudy of ONO-7475 in Combination With ONO-4538 and Gemcitabine Plus Nab-paclitaxel (GnP), the Standard of Care, and ONO-7475 in Combination With GnP in Patients With Pancreatic Cancer [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating ONO-7475 in combination with ONO-4538 and gemcitabine plus nab-paclitaxel (GnP) and ONO-7475 with GnP for metastatic pancreati…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• Abraxane (paclitaxel albumin-bound)
• Gemcitabine (Gemcitabine)
• ONO-4538
• ONO-7475

Snippet

Sponsor: Ono Pharmaceutical Co., Ltd. | Conditions: Metastatic Pancreatic Cancer | Phase 1 | Status: ACTIVE_NOT_RECRUITING